Daniel L Menezes, W. See, A. Risueño, Jianglin Ma, I. L. Torre, B. Skikne, C. Beach, Keshava Kumar, A. Thakurta
{"title":"505:口服阿扎胞苷调节急性髓系白血病(AML)缓解期患者的免疫微环境:QUAZAR AML-001试验的亚分析","authors":"Daniel L Menezes, W. See, A. Risueño, Jianglin Ma, I. L. Torre, B. Skikne, C. Beach, Keshava Kumar, A. Thakurta","doi":"10.1158/1538-7445.AM2021-505","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10518,"journal":{"name":"Clinical Research (Excluding Clinical Trials)","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract 505: Oral azacitidine modulates the immune microenvironment in acute myeloid leukemia (AML) patients in remission: A subanalysis from the QUAZAR AML-001 Trial\",\"authors\":\"Daniel L Menezes, W. See, A. Risueño, Jianglin Ma, I. L. Torre, B. Skikne, C. Beach, Keshava Kumar, A. Thakurta\",\"doi\":\"10.1158/1538-7445.AM2021-505\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10518,\"journal\":{\"name\":\"Clinical Research (Excluding Clinical Trials)\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research (Excluding Clinical Trials)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.AM2021-505\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research (Excluding Clinical Trials)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-505","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract 505: Oral azacitidine modulates the immune microenvironment in acute myeloid leukemia (AML) patients in remission: A subanalysis from the QUAZAR AML-001 Trial